Innate Pharma SA Increase Decrease In Cash And Cash Equivalents
Innate Pharma SA (IPHYF) reported Increase Decrease In Cash And Cash Equivalents of -EUR 38.30 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-04-01
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 6 month as first filed | Increase Decrease In Cash And Cash Equivalents 12 month | Increase Decrease In Cash And Cash Equivalents 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -38.30M EUR 20-F · filed 2026-04-01 | |||
| 2025-06-30 | -12.69M EUR 6-K · filed 2025-09-17 | |||
| 2024-12-31 | -4.21M EUR 20-F · filed 2026-04-01 | |||
| 2024-06-30 | -616.00K EUR 6-K · filed 2025-09-17 | -615.00K EUR 6-K · filed 2024-09-12 | ||
| 2023-12-31 | -13.62M EUR 20-F · filed 2026-04-01 | |||
| 2023-06-30 | -12.81M EUR 6-K · filed 2024-09-12 | |||
| 2022-12-31 | -19.53M EUR 20-F · filed 2025-04-30 | -19.53M EUR 20-F · filed 2023-04-06 | ||
| 2022-06-30 | -807.00K EUR 6-K · filed 2023-09-14 | |||
| 2021-12-31 | -33.04M EUR 20-F · filed 2024-04-04 | -33.04M EUR 20-F · filed 2022-04-04 | ||
| 2021-06-30 | -32.81M EUR 6-K · filed 2022-09-15 | -32.81M EUR 6-K · filed 2021-09-15 | ||
| 2020-12-31 | -66.10M EUR 20-F · filed 2023-04-06 | |||
| 2020-06-30 | -71.34M EUR 6-K · filed 2021-09-15 | |||
| 2019-12-31 | 50.57M EUR 20-F · filed 2022-04-04 | 50.57M EUR 20-F · filed 2020-04-24 | ||
| 2018-12-31 | 52.95M EUR 20-F · filed 2021-04-27 | |||
| 2017-12-31 | -76.54M EUR 20-F · filed 2020-04-24 |